{
    "RADCURE-0359": {
        "question": "Age: 76.4, Sex: Male, ECOG PS: ECOG 1, Smoking PY: 0, Smoking Status: Non-smoker, Ds Site: Esophagus, Subsite: Cervical esophagus, T: T2, N: N1, M : M0, Stage: III, Path: Squamous Cell Carcinoma, HPV: none, Tx Modality: RT alone, Chemo? : none, Dose: 70.0, Fx: 35, Local: none, Regional: Yes, Distant: none, 2nd Ca: S   (suspicious), ContrastEnhanced: 1\nAnswer: ",
        "recruit-recruiter": "1. Radiation Oncologist - Your expertise is strictly limited to radiation therapy planning and dosing for esophageal squamous cell carcinoma, especially in elderly patients with cervical esophageal involvement. - Hierarchy: Radiation Oncologist",
        "initial_assessment-radiation oncologist": "**Step 1: Initial Assessment (without bounding box data)**\n\n- The CT scan is a sagittal view of the head and neck region.\n- Visible anatomical structures include the cervical vertebrae, the airway (pharynx and larynx), and soft tissues of the neck.\n- The esophagus is visible posterior to the trachea and anterior to the cervical spine.\n- The masked region of interest (ROI) is highlighted in blue and appears to correspond to a segment of the cervical esophagus.\n- No obvious gross anatomical abnormalities such as fractures or grossly enlarged lymph nodes are seen in this view.\n- The ROI shows a localized area that may represent a tumor or pathological lesion within the cervical esophagus.\n\n**Step 2: Mapping Bounding Boxes**\n\n- The bounding box coordinates are [[265, 236, 129, 265, 278, 164], [265, 236, 129, 265, 278, 164]].\n- Both bounding boxes are identical, indicating a single volumetric region of interest.\n- These coordinates correspond to a specific 3D volume within the CT scan, likely encompassing the tumor and possibly involved regional lymph nodes.\n- Given the location and the ROI, this volume likely includes the cervical esophageal tumor and adjacent tissues.\n\n**Step 3: Clinical Reasoning**\n\n- Patient is elderly (age 76.4), male, with ECOG performance status 1 (relatively preserved function).\n- Diagnosis: Squamous cell carcinoma of the cervical esophagus, stage III (T2N1M0).\n- No distant metastasis (M0), but regional lymph node involvement (N1).\n- Treatment planned is radiation therapy alone, 70 Gy in 35 fractions, without chemotherapy.\n- The tumor is localized to the cervical esophagus, which is a challenging site due to proximity to critical structures (spinal cord, airway).\n- The presence of suspicious second cancer (S) may complicate prognosis.\n- Radiation dose is curative intent, but cervical esophageal tumors have moderate to poor prognosis due to anatomical constraints and potential for local recurrence.\n- The patient is a non-smoker, which may favor better tolerance to radiation.\n- No chemotherapy may reduce systemic control but may be chosen due to age or comorbidities.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan and ROI confirm a localized cervical esophageal squamous cell carcinoma with regional nodal involvement.\n- The bounding box accurately maps the tumor volume targeted for radiation.\n- Given the patient's age, performance status, and treatment plan (RT alone, 70 Gy), the prognosis is guarded but potentially favorable if local control is achieved.\n- The absence of distant metastasis and non-smoking status are positive prognostic factors.\n- However, the presence of suspicious second cancer and lack of chemotherapy may negatively impact survival.\n- Overall, the patient has a reasonable chance of survival with definitive radiation therapy, but close follow-up is essential.\n\n('Answer:Alive',)",
        "Round 1-role-comment": "radiation oncologist:alive",
        "Round 1-num_agents": 1,
        "Round 2-Turn 1-discuss-participate-radiation oncologist": "No",
        "Round 2-Turn 1-ask_gap-radiation oncologist": "Yes. A medical oncologist is needed to provide expertise on systemic therapy options and chemotherapy considerations, especially given the patient's stage III disease and the decision to proceed with radiation therapy alone. Additionally, a radiologist or diagnostic imaging specialist would be valuable to further characterize the tumor extent and assess for any subtle metastatic disease or second primary cancers.",
        "Round 2-Turn 1-gap_identified-assistant": "- Consult a medical oncologist to provide expertise on systemic therapy options and chemotherapy considerations, especially given the patient's stage III esophageal squamous cell carcinoma and the decision to proceed with radiation therapy alone.  \n- Consult a radiologist or diagnostic imaging specialist to further characterize the tumor extent and assess for any subtle metastatic disease or second primary cancers.",
        "Round 2-Turn 1-gap_recruit-recruiter": "1. Medical Oncologist - Your expertise is strictly limited to systemic therapy decisions, including chemotherapy considerations and immunotherapy options for esophageal squamous cell carcinoma, particularly in stage III disease. - Hierarchy: Medical Oncologist == Radiation Oncologist  \n2. Radiologist - Your expertise is strictly limited to diagnostic imaging interpretation, including contrast-enhanced studies to assess tumor extent, nodal involvement, and evaluation of suspicious second primary cancers in the esophageal region. - Hierarchy: Radiologist == Radiation Oncologist",
        "Round 2-Turn 1-gap_recruited_assessment-medical oncologist": "**Step 1: Initial Assessment (without bounding box data)**\n\n- The CT scan is a sagittal view of the head and neck region, showing bony structures (cervical vertebrae), airway, and soft tissues.\n- The cervical vertebrae are well-aligned without fractures or gross deformities.\n- The airway (pharynx and larynx) is patent.\n- The esophagus is visible posterior to the trachea and anterior to the cervical spine.\n- The masked region of interest (ROI), highlighted in blue, is located in the cervical esophagus region.\n- The ROI appears as a localized soft tissue density, which may represent a tumor or pathological lesion.\n- No obvious grossly enlarged lymph nodes or distant metastases are visible in this view.\n- No signs of airway obstruction or vertebral invasion are noted.\n\n**Step 2: Mapping Bounding Boxes**\n\n- The bounding box coordinates are [[265, 236, 129, 265, 278, 164], [265, 236, 129, 265, 278, 164]], indicating a single volumetric region.\n- These coordinates correspond to a specific 3D volume within the CT scan, likely encompassing the tumor and possibly involved regional lymph nodes.\n- The bounding box overlaps with the masked ROI in the cervical esophagus, confirming the tumor location.\n- The volume likely includes the primary tumor and adjacent soft tissues, possibly including regional lymph nodes.\n\n**Step 3: Clinical Reasoning**\n\n- Patient is a 76.4-year-old male with ECOG performance status 1, indicating relatively preserved functional status.\n- Diagnosis: Squamous cell carcinoma of the cervical esophagus, stage III (T2N1M0).\n- T2 indicates tumor invasion into the muscularis propria but not beyond.\n- N1 indicates regional lymph node involvement.\n- M0 indicates no distant metastasis.\n- Treatment planned is radiation therapy alone (70 Gy in 35 fractions), without chemotherapy.\n- The cervical esophagus is anatomically challenging due to proximity to critical structures (spinal cord, airway).\n- Radiation alone may be less effective than combined chemoradiation but may be chosen due to age or comorbidities.\n- The patient is a non-smoker, which may favor better treatment tolerance.\n- Presence of suspicious second cancer (S) may complicate prognosis.\n- Regional nodal involvement increases risk of recurrence and worsens prognosis.\n- Overall, the patient has a moderate prognosis with definitive radiation therapy alone.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan and ROI confirm a localized cervical esophageal squamous cell carcinoma with regional nodal involvement.\n- The bounding box accurately maps the tumor volume targeted for radiation therapy.\n- Given the patient's age, performance status, and treatment plan (RT alone, 70 Gy), the prognosis is guarded but potentially favorable if local control is achieved.\n- Absence of distant metastasis and non-smoking status are positive prognostic factors.\n- The presence of suspicious second cancer and lack of chemotherapy may negatively impact survival.\n- Close follow-up is essential to monitor for recurrence or progression.\n- Overall, the patient has a reasonable chance of survival with definitive radiation therapy.\n\n('Answer:Alive',)",
        "Round 2-Turn 1-gap_recruited_assessment-radiologist": "**Step 1: Initial Assessment (without bounding box data)**\n\n- The CT scan is a sagittal contrast-enhanced image of the head and neck region.\n- Visible anatomical structures include the cervical vertebrae, the airway (pharynx and larynx), and soft tissues of the neck.\n- The esophagus is visible posterior to the trachea and anterior to the cervical spine.\n- The masked region of interest (ROI) is highlighted in blue and corresponds to a segment of the cervical esophagus.\n- No obvious fractures or grossly enlarged lymph nodes are seen in this view.\n- The ROI appears to represent a localized lesion or tumor within the cervical esophagus.\n- The surrounding soft tissues and airway appear preserved without gross invasion or compression.\n\n**Step 2: Mapping Bounding Boxes**\n\n- The bounding box coordinates are [[265, 236, 129, 265, 278, 164], [265, 236, 129, 265, 278, 164]].\n- Both bounding boxes are identical, indicating a single volumetric region of interest.\n- These coordinates correspond to a specific 3D volume within the CT scan, likely encompassing the tumor and possibly involved regional lymph nodes.\n- Given the location and the ROI, this volume likely includes the cervical esophageal tumor and adjacent tissues.\n\n**Step 3: Clinical Reasoning**\n\n- Patient is elderly (age 76.4), male, with ECOG performance status 1 (relatively preserved function).\n- Diagnosis: Squamous cell carcinoma of the cervical esophagus, stage III (T2N1M0).\n- No distant metastasis (M0), but regional lymph node involvement (N1).\n- Treatment planned is radiation therapy alone, 70 Gy in 35 fractions, without chemotherapy.\n- The tumor is localized to the cervical esophagus, a challenging site due to proximity to critical structures (spinal cord, airway).\n- The presence of suspicious second cancer (S) may complicate prognosis.\n- Radiation dose is curative intent, but cervical esophageal tumors have moderate to poor prognosis due to anatomical constraints and potential for local recurrence.\n- The patient is a non-smoker, which may favor better tolerance to radiation.\n- No chemotherapy may reduce systemic control but may be chosen due to age or comorbidities.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan and ROI confirm a localized cervical esophageal squamous cell carcinoma with regional nodal involvement.\n- The bounding box accurately maps the tumor volume targeted for radiation.\n- Given the patient's age, performance status, and treatment plan (RT alone, 70 Gy), the prognosis is guarded but potentially favorable if local control is achieved.\n- The absence of distant metastasis and non-smoking status are positive prognostic factors.\n- However, the presence of suspicious second cancer and lack of chemotherapy may negatively impact survival.\n- Overall, the patient has a reasonable chance of survival with definitive radiation therapy, but close follow-up is essential.\n\n('Answer:Alive',)",
        "Round 2-Turn 1-Round 2-Turn 1-gap_recruited_discuss-participate-medical oncologist": "No",
        "Round 2-Turn 1-Round 2-Turn 1-gap_recruited_discuss-participate-radiologist": "No",
        "Round 2-role-comment": "radiation oncologist:alive|medical oncologist:alive|radiologist:alive",
        "Round 2-num_agents": 3,
        "num_cooperations-panel": 0,
        "decision-Moderator": "('Answer: Alive',)"
    }
}